The Carol and Gene Ludwig Center for Research on Neurodegeneration

Ludwig Center Events

For more information, please email Nadia Propp at np2221@cumc.columbia.edu.

Recent Event:

The Ludwig Scholars Mini Symposium group 2025

Pictured (left to right): Wassim Elyaman, Michael Shelanski, Clarissa Waites, Carol Troy, Andrew Teich, Elizabeth Bradshaw, Ulrich Hengst, Annie Lee, Badri Vardarajan, Carol Mason, Lawrence Honig, Itamar Kahn, Ofra Weinberger, Vilas Menon, and Peter St George-Hyslop.

The Ludwig Scholars Mini Symposium

Final Progress Reports and Announcing New Cohort of Scholars’25

The Ludwig Scholars group photo 2025

Pictured (left to right): Elizabeth Bradshaw, Urlich Hengst, Clarissa Waites, Lawrence Honig, Andrew Teich, and Peter St George-Hyslop.

The Ludwig Scholars first mini symposium convened on July 23, 2025. The event was a representation of the Ludwig Center’s Pilot Program in Neurodegeneration and the exceptional work of its scholars. The inaugural scholars awarded in 2023 presented their final scientific progress, while a new cohort of scholars was formally introduced.

This event highlighted not only the innovative and translational nature of the research, but also the collaborative, team science culture that defines the Ludwig Center. As a testament to the program’s success, both inaugural pilot projects are serving as the foundation for upcoming R01 submissions and scientific publications. 

The Ludwig Center Pilot Program in Neurodegeneration supports translational efforts that bridge basic science and clinical application, ultimately accelerating the development of therapeutic strategies that have the potential to transform Alzheimer’s disease.

Annual Ludwig Research Symposium

  • 2025 Symposium Topic: Genetics and Biology of Resilience and Resistance to Alzheimer’s Disease
  • 2024 Symposium Topic: Cellular and Molecular Mechanisms Underlying Vascular Contributions to Alzheimer’s Disease

Please follow this link for more information.

Ludwig Center Seminars Series

  • January 15, 2025
    Dr. Michal Schwartz Weizmann, Institute of Science, Rehovot, Israel
    Brain-Immune Ecosystem: Targeting Inhibitory Immune Checkpoint to Restore Brain-Immune Cross-Talk to Defeat Alzheimer’s Disease

Ludwig Scholars Monthly Seminars

  • January 12, 2026
    Dr. Andy Teich
    AI approaches to digital pathology
  • December 8, 2025
    Dr. Larry Honig
    CAA associated brain bleeding
  • November 10, 2025
    Dr. Ulrich Hengst
    Pathogenic transcription factor dimerization in Alzheimer's disease
  • August 11, 2025
    Dr. Wassim Elyaman
    T Time in Degenerating Brain
  • July 14, 2025
    Mini Symposium
  • June 9, 2025
    Dr. Annie Lee 
    Multi-Omics of Cardio-Cerebrovascular Risk Factors in Alzheimer’s Disease
  • May 12, 2025
    Dr. Abid Hussaini
    Decoding neuronal dysfunction in brain regions most vulnerable to Alzheimer’s disease
  • April 14, 2025
    Dr. Carol Troy
    Development of a non-invasive cell permeant peptide to treat neurovascular disease
  • ​​​​​​February 10, 2025
    Dr. Vilas Menon
    Cell type signatures associated with cognitive resilience to AD pathology​​​​​​
  • January 13, 2025
    Dr. Caghan Kizil
    A new pathological mechanism of APOE4-mediated blood-brain barrier disruption and potential therapeutic molecules
  • December 9, 2024
    Dr. Badri N. Vardarajan
    Plasma metabolomics in Alzheimer’s Disease
  • November 11, 2024
    Dr. Elizabeth M. Bradshaw
    Therapeutically Targeting the Innate Immune System in AD
  • October 14, 2024
    Dr. Peter St George-Hyslop
    Structural and Functional Biology of Alzheimer Disease Risk Genes Modulating Microglial Signaling Pathways